REGIONAL TREATMENT MODALITY is intended to identify the dominant modality
of therapy delivered to the primary volume of interest. In some cases,
it may be appropriate to choose a code for its academic or economic
interest, even though it may not reflect the majority of the patient's
therapy. For example, a patient with carcinoma of the nasopharynx may
receive original treatment using a linear accelerator and then have a
boost with High-Dose-Rate (HDR) brachytherapy. In a department with a
special interest in brachytherapy, the code 15 would be chosen.
This field can be useful in assessing resource utilization, planning for
expansion, or monitoring quality. It should be used at the discretion of
the Radiation Oncologist.
Enter the REGIONAL TREATMENT MODALITY code.
Enter the REGIONAL TREATMENT MODALITY code description.